Dimethylamine

Dimethylamine

SCHEMBL7961636

CCCc1nc(-c2ccccc2)no1.CNC

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.64
HRH3 Q9Y5N1 1/20 0.64
RAB9A P51151 8/20 0.64
NPC1 O15118 7/20 0.64
L3MBTL1 Q9Y468 7/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2C19 P33261 1/20 0.64
SMN1; SMN2 Q16637 4/20 0.63
HTT P42858 1/20 0.63
NOTUM Q6P988 1/20 0.58
ALDH1A1 P00352 3/20 0.56
MEN1 O00255 1/20 0.56
TSHR P16473 1/20 0.56
KMT2A Q03164 1/20 0.56
MAPT P10636 2/20 0.55
POLB P06746 1/20 0.55
TDP1 Q9NUW8 4/20 0.54
ATM Q13315 1/20 0.54
GAA P10253 1/20 0.53
NAMPT P43490 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14288613 0.95 RAB9A (0.70) HTR1AHRH3RAB9ANPC1L3MBTL1
Dimethylamine SCHEMBL7961651 0.91 ALDH1A1 (0.61) HTR1AHRH3RAB9ANPC1L3MBTL1
Dimethylamine SCHEMBL7947230 0.87 NOTUM (0.62) HTR1AHRH3RAB9ANPC1L3MBTL1
SCHEMBL91541 0.81 NOTUM (0.68) HTR1AHRH3RAB9ANPC1L3MBTL1
SCHEMBL16975850 0.80 SMN1; SMN2 (0.71) RAB9ANPC1L3MBTL1SMN1; SMN2HTT
SCHEMBL5795375 0.80 SMN1; SMN2 (0.69) HTR1AHRH3RAB9ANPC1L3MBTL1
SCHEMBL10914161 0.79 RAB9A (0.69) HTR1AHRH3RAB9ANPC1L3MBTL1
SCHEMBL19131259 0.78 SMN1; SMN2 (0.64) HTR1AHRH3RAB9ANPC1CYP1A2
SCHEMBL12396054 0.78 PPARA (0.82) HRH3RAB9ANPC1L3MBTL1CYP1A2
Oxolamine SCHEMBL893333 0.78 HTR1A (1.00) HTR1AHRH3RAB9ANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed